Nuclide

What changed: Metastatic hormone-sensitive prostate cancer

Indication page →

Every dated change on the records linked to Metastatic hormone-sensitive prostate cancer, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Approval2Regulatory1Trial result4Milestone8This record1
FollowWatch this record and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

July 2026 · 1

2026 · 1

2025 · 1

2024 · 1

2022 · 1

2021 · 1

2019 · 2

2018 · 1

2017 · 1

2016 · 2

2015 · 2

1941 · 1